Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Dallos

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'Angelo
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2013
Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signalingBrendan J Quinn, Matthew Dallos, Hiroshi Kitagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialDeaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Immunotherapy|August 4, 2016
Current status of engineered T-cell therapy for synovial sarcomaMatthew Dallos, William D Tap, Sandra P D'Angelo
Cancer Prevention Research (Philadelphia, Pa.)|June 18, 2013
Inhibition of lung tumorigenesis by metformin is associated with decreased plasma IGF-I and diminished receptor tyrosine kinase signalingBrendan J Quinn, Matthew Dallos, Hiroshi Kitagawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer Through Multi-Modal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical TrialDeaglan McHugh, Matthew Dallos, Min Yuen Teo, et al.
Pageof 1